Facilitated By

San Antonio Medical Foundation

News

  • Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as ...

    ... San Antonio Breast Cancer Symposium (SABCS) today, Wednesday, December ... Harnessing the power of biotechnology, chemistry and genetic ...

  • Menarini Group and MEDSIR Present the Phase III Study ADELA - BioSpace

    The study was presented by the Menarini Group and MEDSIR at the San Antonio ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare ...

  • 2,500 San Antonio volunteers sought for the NCAA Men's Final Four this spring | TPR

    Bioscience-Medicine · Border & Immigration · Economy & Labor ... 2,500 San Antonio volunteers sought for the NCAA Men's Final Four this spring.

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...

    ... San Antonio Breast Cancer Symposium. December 11, 2024 at 07:05 am EST ... 55. Sector. Biotechnology & Medical Research. Calendar. 2025-03-19 - Q4 ...

  • Christina Curtis honored for achievements in breast cancer research - Stanford Medicine

    She is the first person to receive both awards in the same year and will be presented the awards at the 2024 San Antonio Breast Cancer Symposium.